Blogs
Sustainable funding of cell and gene therapies: bluebird bio puts the ball in the payer’s court
By Nader Murad, Associate Consultant Email: [email protected] At JPMorgan’s 37th Healthcare Conference in 2019, bluebird bio provided its strategic outlook and plans for the year